Aldeyra Therapeutics (137.F) Q2 2024 Earnings

2MayConfirmed
Q4 2023
Q2 2024
-0.13
-0.11
-0.09
-0.07

Details

Expected EPS
-0.1031135625
Actual EPS
-0.13049400000000003
Surprise EPS
-0.03
Surprise Percent
+26.55%

Description

Aldeyra Therapeutics (137.F) has reported earnings of -0.13049400000000003 per share for Q2 2024.

0 Comments

Share your thoughts